ADJUVANT CAPITALGlenn Rockman

https://vitrivaxbio.com/wp-content/uploads/2024/07/Glenn-Rockman_450.jpg

Glenn Rockman is a finance professional with more than 20 years of experience in venture capital and investment banking. He is Managing Partner at Adjuvant Capital, a life sciences investment firm focused on global public health, where he oversees the firm’s investment practice and its operations. Prior to founding Adjuvant Capital in 2018, Glenn co-led the investment team at the Gates Foundation-sponsored Global Health Investment Fund (GHIF), a pioneering venture fund in the life sciences sector backed by multi-national pharmaceutical companies, development finance institutions, family offices, and foundations. Previously, Glenn was an Executive Director in J.P. Morgan’s Social Finance unit, where he helped the firm’s non-profit clients maximize the financial resources available to advance their missions. Glenn earned a BA in public policy from the Princeton School of Public and International Affairs.